Effect of microbial heat shock proteins on airway inflammation and hyperresponsiveness

Area of Science:

• Immunology
• Allergy Research
• Microbial Protein Research

Background:

• Microbial heat shock proteins (hsp) are linked to Th1 immune responses.
• Allergic airway inflammation and airway hyperresponsiveness (AHR) are significant health concerns.
• Investigating microbial hsp for therapeutic potential in allergic diseases is warranted.

Purpose of the Study:

• To evaluate the effects of five microbial heat shock proteins (hsp) on a murine model of allergic airway inflammation and AHR.
• To determine if M. leprae hsp has a therapeutic effect on established allergic airway inflammation.

Main Methods:

• A mouse model of allergic airway inflammation was established using ovalbumin (OVA) sensitization and challenge.
• Mice received intraperitoneal injections of five different microbial hsp prior to sensitization and challenge.
• Key markers of allergic inflammation, including IgE levels, eosinophilia, methacholine responsiveness, and cytokine profiles, were assessed.

Main Results:

• Administration of Mycobacterium leprae hsp significantly prevented the development of AHR and airway eosinophilia in a dose-dependent manner.
• M. leprae hsp treatment suppressed Th2 cytokines (IL-4, IL-5) and increased Th1 cytokines (IL-10, IFN-gamma) in bronchoalveolar lavage fluid.
• Other microbial hsp tested did not demonstrate significant protective effects against allergic airway inflammation.
• Depletion of gamma/delta T lymphocytes abrogated the protective effect of M. leprae hsp, suggesting their involvement.

Conclusions:

• Mycobacterium leprae hsp exhibits unique properties that can ameliorate allergic airway inflammation and airway hyperresponsiveness.
• M. leprae hsp may represent a novel therapeutic strategy for allergic airway diseases.
• The therapeutic effect of M. leprae hsp appears to be mediated, at least in part, through gamma/delta T lymphocytes.